carfilzomib, cyclophosphamide and dexamethasone (combination therapy)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for carfilzomib, cyclophosphamide and dexamethasone (combination therapy), covering 2023-07-03 to 2023-07-03. Get the full timeline:
Most recent: Clinical Trial Update: Study of Carfilzomib, Cyclophosphamide and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients [Phase 1, Phase 2]